128 related articles for article (PubMed ID: 38311062)
21. Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma.
Devin J; Cañeque T; Lin YL; Mondoulet L; Veyrune JL; Abouladze M; Garcia De Paco E; Karmous Gadacha O; Cartron G; Pasero P; Bret C; Rodriguez R; Moreaux J
Cancer Res; 2022 Mar; 82(6):998-1012. PubMed ID: 35078814
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of hydrogen peroxide- and 4-hydroxy-2-nonenal-induced cell death in HT22 cells.
Ishimura A; Ishige K; Taira T; Shimba S; Ono S; Ariga H; Tezuka M; Ito Y
Neurochem Int; 2008; 52(4-5):776-85. PubMed ID: 17977619
[TBL] [Abstract][Full Text] [Related]
23. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
Lee J; Roh JL
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
[TBL] [Abstract][Full Text] [Related]
24. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
[TBL] [Abstract][Full Text] [Related]
25. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
[TBL] [Abstract][Full Text] [Related]
26. S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma.
Uddin S; Hussain A; Ahmed M; Belgaumi A; Al-Dayel F; Ajarim D; Bavi P; Al-Kuraya KS
J Pathol; 2008 Dec; 216(4):483-94. PubMed ID: 18850583
[TBL] [Abstract][Full Text] [Related]
27. PAQR3 facilitates the ferroptosis of diffuse large B-cell lymphoma via the regulation of LDLR-mediated PI3K/AKT pathway.
Song X; Zhang W; Yu N; Zhong X
Hematol Oncol; 2024 Jan; 42(1):e3219. PubMed ID: 37690092
[TBL] [Abstract][Full Text] [Related]
28. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract][Full Text] [Related]
29. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
[TBL] [Abstract][Full Text] [Related]
30. Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma.
Yan S; Shang Q; Fan Z; Yang Y; Liu Y; Gao H; Chen K; Liang F; Li X; Zhang Q; Yan H
J Immunol Res; 2022; 2022():5633096. PubMed ID: 36213322
[TBL] [Abstract][Full Text] [Related]
31. RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.
Xie W; Wang J; Tian S; Zhao H; Cao L; Liang Z; Yang J; Zhao Y; Wang B; Jiang F; Ma J
Oncogene; 2024 May; 43(19):1463-1475. PubMed ID: 38514855
[TBL] [Abstract][Full Text] [Related]
32. ACSL1-induced ferroptosis and platinum resistance in ovarian cancer by increasing FSP1 N-myristylation and stability.
Zhang Q; Li N; Deng L; Jiang X; Zhang Y; Lee LTO; Zhang H
Cell Death Discov; 2023 Mar; 9(1):83. PubMed ID: 36882396
[TBL] [Abstract][Full Text] [Related]
33. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
[TBL] [Abstract][Full Text] [Related]
34. Lipid-derived electrophiles inhibit the function of membrane channels during ferroptosis.
Van Kessel ATM; Cosa G
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2317616121. PubMed ID: 38743627
[TBL] [Abstract][Full Text] [Related]
35. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis in RAW 264.7 cells exposed to 4-hydroxy-2-nonenal: dependence on cytochrome C release but not p53 accumulation.
Haynes RL; Brune B; Townsend AJ
Free Radic Biol Med; 2001 Apr; 30(8):884-94. PubMed ID: 11295531
[TBL] [Abstract][Full Text] [Related]
37. The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach.
Xia X; Fan X; Zhao M; Zhu P
Curr Gene Ther; 2019; 19(2):117-124. PubMed ID: 31264548
[TBL] [Abstract][Full Text] [Related]
38. Synergistic disruption of BTK and BCL-2 causes apoptosis while inducing ferroptosis in double-hit lymphoma.
Setiawan SA; Liu WZ; Weng PW; Lee CH; Yadav VK; Hardianti MS; Yeh CT; Chao TY
Eur J Pharmacol; 2023 Mar; 943():175526. PubMed ID: 36693553
[TBL] [Abstract][Full Text] [Related]
39. Fludarabine Enhances Radiosensitivity by Promoting Ferroptosis in B-Cell Lymphoma.
Long Q; Tao H; Wang P; Wu B; Zhu Q; Chen H; Lao G; Yang Y; Liu G; Liu S; Wu Y
Radiat Res; 2024 Mar; 201(3):224-239. PubMed ID: 38235545
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance associated protein 1 together with glutathione plays a protective role against 4-hydroxy-2-nonenal-induced oxidative stress in bovine aortic endothelial cells.
Takahashi K; Tatsunami R; Sato K; Tampo Y
Biol Pharm Bull; 2012; 35(8):1269-74. PubMed ID: 22863924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
